CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Clinical trials for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CANCER TREATMENT-INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to fix chemo side effect that delays cancer care
Disease control Recruiting nowThis study tests a drug called QL0911 for cancer patients whose platelet levels drop too low due to chemotherapy. Low platelets can delay treatment or require dose changes. The trial will see if QL0911 safely raises platelet counts so patients can complete their chemo on schedule…
Matched conditions: CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
Cord blood infusion aims to boost platelets in cancer patients
Disease control Recruiting nowThis study tests if a single infusion of umbilical cord blood can safely raise platelet counts in 25 cancer patients aged 12 to 65 whose platelets dropped due to chemotherapy or other cancer treatments. Participants receive the infusion and are monitored for 28 days for platelet …
Matched conditions: CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC